Join
Login
Join
Login
"Where Everyone Has an MBA"
Tel: (612) 246-4616
Home
Financial Analysis
Companies
Industries
Glossary
About
Frequently Asked Questions
User Testimonials
Contact Us
Navigation
Home
Financial Analysis
Companies
Industries
Glossary
About
- Frequently Asked Questions
- User Testimonials
Contact Us
Biostax Corp - SIC # 2834 - PHARMACEUTICAL PREPARATIONS
Ticker
Exchange
SIC #
Website
Latest Ticker
BTAX
Over the counter
2834
https://www.biostaxcorp.com/
Select one of the four (4) financial statement analysis reports below to view the ratio analysis report for your selected company:
Latest Headlines for Biostax Corp
Biostax Corp. to Participate in U.S. Business Action to End HIV Annual Coalition Meeting and World AIDS Day Reception
- Nov 30th, 2023 2:45 pm
Biostax Announces a Director Appointment of Influential Business Leader Craig Suro
- Nov 15th, 2023 2:30 pm
Biostax Announces the Appointment of Ms. Mary Clay Caperton to its Board of Directors
- Nov 2nd, 2023 2:10 pm
Biostax Announces FINRA Approval for Name and Ticker Symbol Change, Signals Entry into Global Substance Abuse Commercial Markets and Pioneering HIV Treatment
- Oct 24th, 2023 1:15 pm
Scroll